Loading...
XHKG
0460
Market cap1.58bUSD
Dec 05, Last price  
1.33HKD
1D
-0.75%
1Q
-19.39%
Jan 2017
-38.43%
IPO
-52.84%
Name

Sihuan Pharmaceutical Holdings Group Ltd

Chart & Performance

D1W1MN
XHKG:0460 chart
P/E
—
P/S
5.87
EPS
—
Div Yield, %
1.58%
Shrs. gr., 5y
-0.43%
Rev. gr., 5y
-7.96%
Revenues
1.90b
+2.18%
161,776,000286,349,000510,048,000708,907,0001,036,881,0002,242,063,0003,042,531,0004,732,700,0003,084,236,0003,167,211,0003,185,699,0002,745,809,0002,917,405,0002,878,318,0002,464,226,0003,038,391,0002,181,189,0001,860,539,0001,901,109,000
Net income
-217m
L+301.10%
90,453,000179,266,000237,059,000326,316,000522,065,000824,048,000904,402,0001,303,012,0001,671,281,0002,062,378,0001,708,239,0001,448,935,0001,619,956,000-2,709,364,000473,382,000416,509,000-1,951,214,000-54,017,000-216,662,000
CFO
244m
+22.26%
75,980,000182,263,000261,169,000385,648,000380,101,000712,934,0001,046,064,0001,510,633,0001,760,936,0001,568,610,0002,018,026,0001,917,590,0001,792,794,0001,417,858,000227,131,000665,293,00046,493,000199,487,000243,887,000
Dividend
Sep 27, 20240.021 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.
URL
http://www.sihuanpharm.com/
IPO date
Oct 28, 2010
Employees
3,241
Domiciled in
CN
Incorporated in
BM

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT